Germinal Center B Cells Regulate Their Capability to Present Antigen by Modulation of HLA-DO
Open Access
- 15 April 2002
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 195 (8), 1063-1069
- https://doi.org/10.1084/jem.20012059
Abstract
Peptide acquisition by MHC class II molecules is catalyzed by HLA-DM (DM). In B cells, HLA-DO (DO) inhibits or modifies the peptide exchange activity of DM. We show here that DO protein levels are modulated during B cell differentiation. Remarkably, germinal center (GC) B cells, which have low levels of DO relative to naive and memory B cells, are shown to have enhanced antigen presentation capabilities. DM protein levels also were somewhat reduced in GC B cells; however, the ratio of DM to DO in GC B cells was substantially increased, resulting in more free DM in GC B cells. We conclude that modulation of DM and DO in distinct stages of B cell differentiation represents a mechanism by which B cells regulate their capacity to function as antigen-presenting cells. Efficient antigen presentation in GC B cells would promote GC B cell–T cell interactions that are essential for B cells to survive positive selection in the GC.Keywords
This publication has 23 references indexed in Scilit:
- Dynamics of Major Histocompatibility Complex Class II Compartments during B Cell Receptor–mediated Cell ActivationThe Journal of Experimental Medicine, 2002
- Nonclassical MHC Class II MoleculesAnnual Review of Immunology, 2000
- Negative Regulation by HLA-DO of MHC Class II-Restricted Antigen ProcessingScience, 1997
- Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant.The Journal of Experimental Medicine, 1996
- HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loadingCell, 1995
- Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by Rapid Up-Regulation of B7-1 and B7-2Immunity, 1995
- Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.The Journal of Experimental Medicine, 1995
- Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cellsImmunity, 1994
- T Cell-Dependent B Cell ActivationAnnual Review of Immunology, 1993
- Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells.The Journal of Experimental Medicine, 1983